Tablet Supplement Manufacturing: High-Precision Compression & Turnkey B2B Solutions

Direct compression (DC) is chosen when the active raw materials possess high bulk density, uniform particle size distribution, and intrinsic compressibility. It is the most economical process and avoids exposing heat- or moisture-sensitive nutrients to thermal drying. Conversely, wet granulation is required for cohesive botanical powders, high-dose mineral complexes (such as Calcium Carbonate or Magnesium Oxide), and formulas where un-granulated powders would segregate in the hopper during high-speed rotary compression. Wet granulation coats particles with a liquid binder, forming dense, spherical granules that flow evenly and compress into hard, low-friability tablets.

Tablet compression defects stem from improper pre-compression air entrainment, excess moisture, or uncalibrated ejection forces. At Enova Science, our laboratory analyzes particle size distribution (PSD), Loss on Drying (LOD), and Carr’s Compressibility Index before scaling. During compression, our automated rotary presses employ dual-stage compression (pre-compression and main compression) to gradually purge entrapped air. We precisely balance internal lubricants (such as organic rice concentrate or magnesium stearate) to eliminate die wall friction and punch face sticking while maintaining targeted disintegration profiles.

Yes. We specialize in clean-label tablet supplement manufacturing. We replace synthetic binders like microcrystalline cellulose (MCC), polyvinylpyrrolidone (PVP), and magnesium stearate with USDA Organic certified acacia fiber, organic tapioca dextrose, bamboo silica, and organic rice hull concentrates. For aesthetic tablet coatings, we use aqueous, solvent-free plant polysaccharide films that are completely free of titanium dioxide, artificial FD&C dyes, polyethylene glycol (PEG), and talc.

Our private label stock tablet formulas start at 5,000 finished bottles. Custom tablet formulations engineered from your ingredient deck typically begin at 100,000 tablets per run, with significant volume discounts at 250,000, 500,000, and 1,000,000+ units. Formal cost proposals are generated within 48 hours, R&D pilot samples are delivered in approximately 5 working days, and standard commercial turnkey production runs require approximately 8 weeks from final art and raw material approval.

Every production batch operates under strict NSF GMP and cGMP guidelines. In-process checks take place every 15 to 30 minutes, measuring tablet weight uniformity, thickness, hardness, and friability. Finished products undergo full analytical laboratory testing for active potency assay, heavy metals (Lead, Cadmium, Arsenic, Mercury), microbial limits (Total Aerobic Count, Yeast & Mold, E. coli, Salmonella), and allergen verification. Every shipment is delivered with an executed Master Batch Record summary, Certificate of Analysis (CoA), and complete documentation for Amazon Seller Central or international customs export.

Absolutley. We operate advanced dual-feed rotary presses capable of compressing distinct bi-layer tablets that isolate reactive ingredients or combine fast/slow dissolution profiles. For chewable formulations, our flavor chemists utilize non-cariogenic polyols (xylitol, erythritol, mannitol) and organoleptic masking agents to cover bitter botanical notes while maintaining ideal chewable friability that protects dental work.

Yes. Enova Science exports dietary supplements globally. We provide Certificates of Free Sale (CFS), cGMP Certificates, BSE/TSE-free attestations, allergen declarations, and customized label compliance reviews tailored to destination markets across North America, Europe, Asia-Pacific, Latin America, and the Middle East.